- Home
- DHY vs BTMD Comparison
DHY vs BTMD Comparison
Compare DHY & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHY
- BTMD
- Stock Information
- Founded
- DHY 1998
- BTMD 2012
- Country
- DHY United States
- BTMD United States
- Employees
- DHY N/A
- BTMD N/A
- Industry
- DHY Finance/Investors Services
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- DHY Finance
- BTMD Health Care
- Exchange
- DHY Nasdaq
- BTMD Nasdaq
- Market Cap
- DHY 220.7M
- BTMD 127.8M
- IPO Year
- DHY N/A
- BTMD N/A
- Fundamental
- Price
- DHY $2.10
- BTMD $3.42
- Analyst Decision
- DHY
- BTMD Buy
- Analyst Count
- DHY 0
- BTMD 2
- Target Price
- DHY N/A
- BTMD $6.00
- AVG Volume (30 Days)
- DHY 569.1K
- BTMD 161.7K
- Earning Date
- DHY 01-01-0001
- BTMD 11-11-2025
- Dividend Yield
- DHY 9.10%
- BTMD N/A
- EPS Growth
- DHY N/A
- BTMD 642.53
- EPS
- DHY N/A
- BTMD 0.88
- Revenue
- DHY N/A
- BTMD $199,073,000.00
- Revenue This Year
- DHY N/A
- BTMD N/A
- Revenue Next Year
- DHY N/A
- BTMD $4.85
- P/E Ratio
- DHY N/A
- BTMD $3.92
- Revenue Growth
- DHY N/A
- BTMD 6.32
- 52 Week Low
- DHY $1.77
- BTMD $2.76
- 52 Week High
- DHY $2.08
- BTMD $6.98
- Technical
- Relative Strength Index (RSI)
- DHY 48.75
- BTMD 51.62
- Support Level
- DHY $2.07
- BTMD N/A
- Resistance Level
- DHY $2.12
- BTMD $3.54
- Average True Range (ATR)
- DHY 0.02
- BTMD 0.14
- MACD
- DHY 0.00
- BTMD -0.10
- Stochastic Oscillator
- DHY 50.00
- BTMD 94.20
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.